Deep Genomics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 46
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $40M
Latest Deal Amount
  • Investors
  • 11

Deep Genomics General Information

Description

Developer of an AI-Powered genetic medicine discovery platform designed to interpret genetic variation. The company's AI platform uses throughput assays and advanced robotics systems to generate billions of data points and built dozens of engineered and validated machine learning systems that support drug development, enabling researchers to classify, prioritize, interpret and link genetic variants, whether natural or therapeutic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Technology Systems
Primary Office
  • MaRS Centre, 661 University Avenue
  • Suite 480
  • Toronto, Ontario M5G 1M1
  • Canada

Deep Genomics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 07-Jan-2020 $40M 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 14-Aug-2017 0000 0000 Completed Startup
2. Seed Round 18-Nov-2015 $8M $5M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Deep Genomics’s complete valuation and funding history, request access »

Deep Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an AI-Powered genetic medicine discovery platform designed to interpret genetic variation. The company's AI
Drug Discovery
Toronto, Canada
46 As of 2020
0000
00000000000 0000

00000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
00000 0000000000 0000000000 0000000
Paris, France
000 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000 0000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
France
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Deep Genomics Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Owkin Venture Capital-Backed Paris, France 000 000.00 00000000000 000.00
000 000000 Venture Capital-Backed France 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
0000000 00000000 Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
0000000 Venture Capital-Backed San Mateo, CA 0 00.000 00000000000 00.000
You’re viewing 5 of 32 competitors. Get the full list »

Deep Genomics Executive Team (4)

Name Title Board Seat Contact Info
Brendan Frey Ph.D Co-Founder & Chief Executive Officer
Steve Jurvetson Advisor
Vinod Khosla Advisor
To view Deep Genomics’s complete executive team members history, request access »

Deep Genomics Board Members (1)

Name Representing Role Since
Dion Madsen Amplitude Ventures Board Member 000 0000
To view Deep Genomics’s complete board members history, request access »

Deep Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deep Genomics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amplitude Ventures Venture Capital Minority 000 0000 000000 0
Future Ventures (San Francisco) Venture Capital Minority 000 0000 000000 0
Magnetic Ventures Venture Capital Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
11.2 Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »